FIELD: chemistry.
SUBSTANCE: invention relates to 2-[6-methyl-3-(thien-2-yl)-5-phenyl-5,6-dihydro-4H-[1,2,4,5]tetrazin-1-yl]-benzothiazole I, having antiviral activity against Coxsackie B3 virus.
EFFECT: said compound can be used to treat enteroviral infections caused by Coxsackie virus B3.
1 cl, 1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
2-[5-(4-METHOXY)-3-PHENYL-5,6-DIHYDRO-4H-[1,2,4,5]TETRAZIN-1-YL]-BENZOTHIAZOLES WITH ANTIVIRAL ACTIVITY AGAINST COXSACKIE B3 VIRUSES | 2022 |
|
RU2783659C1 |
3-NITRO-4-HYDROXY-7-PROPARGYLTHIO-[1,2,4]TRIAZOLO[5,1c][1,2,4]TRIAZINE AND 3-NITRO-4-HYDROXY-7-ETHYLTHIO-[1,2,4]TRIAZOLO[5,1c][1,2,4]TRIAZINE WITH ANTIVIRAL ACTIVITY | 2019 |
|
RU2775551C2 |
AN ANTIVIRAL AGENT AGAINST SARS-COV-2 CORONAVIRUS | 2022 |
|
RU2788762C1 |
DIMETHYL 7-METHYL-2-(PYRROLIDINE-1-yl)-4-PHENYLPYRROLO[2,1-ƒ][1,2,4]TRIAZINE-5,6-DICARBOXYLATE AND DIMETHYL 7-METHYL-2-(4-R-PHENYL)-4-(4-R-PHENYL)PYRROLO[2,1-ƒ][1,2,4]TRIAZINE-5,6-DICARBOXYLATES EXHIBITING ANTIVIRAL ACTIVITY | 2021 |
|
RU2790376C1 |
AGENT POSSESSING ANTIVIRAL ACTION AGAINST TICK-BORNE ENCEPHALITIS VIRUSES AND HERPES SIMPLEX TYPE I | 2018 |
|
RU2697887C1 |
COMPOUND 6,8-DIFLUORO-2-(4-(TRIFLUOROMETHYL)PHENYL)CHROMAN-4-ONE AS INHIBITOR OF REPRODUCTION OF INFLUENZA A AND B VIRUSES AND METHOD FOR PRODUCTION THEREOF | 2023 |
|
RU2826250C1 |
ANTIVIRAL AGENT AGAINST HERPES SIMPLEX VIRUS TYPE 1 | 2022 |
|
RU2782935C1 |
ANTIVIRAL AGENT AGAINST HUMAN HERPESVIRUS TYPE I AND ENTEROVIRUS B | 2022 |
|
RU2798659C1 |
6-(2'-AMINO-2'-CARBOXYETHYLTHIO)-2-METHYLTHIO-4-PIVALOYLOXY-METHYL-1,2,4-TRIAZOLO[5,1-c] 1,2,4-TRIAZIN-7(4H)-ONE | 2011 |
|
RU2455304C1 |
ANTIVIRAL COMPOSITION | 2018 |
|
RU2697886C1 |
Authors
Dates
2025-03-14—Published
2023-11-22—Filed